US Representative

Tim Moore 2025-2026 Regular Session - Authored & Sponsored Legislation (Page 8)

Legislative Session

Co-Sponsor of Legislation

US

Us Congress 2025-2026 Regular Session

Us Congress House Bill HB649

Introduced
1/23/25  
Refer
1/23/25  
Whole Milk for Healthy Kids Act of 2025
US

Us Congress 2025-2026 Regular Session

Us Congress House Bill HB654

Introduced
1/23/25  
Taking Account of Bureaucrats' Spending Act of 2025 or the TABS Act of 2025 This bill restructures the Consumer Financial Protection Bureau and renames it as the Consumer Financial Empowerment Agency. The new agency is established as an independent agency outside of the Federal Reserve System.The bill also changes the funding structure of the agency by prohibiting the transfer of funds to the agency from the Federal Reserve System and by authorizing congressional appropriations for FY2026-FY2027.
US

Us Congress 2025-2026 Regular Session

Us Congress House Bill HB685

Introduced
1/23/25  
Support And Value Expectant Moms and Babies Act of 2025 or the SAVE Moms and Babies Act of 2025This bill prohibits the Food and Drug Administration (FDA) from approving any new drug (either as a brand-name drug or a generic) intended to terminate a pregnancy and imposes additional restrictions on such drugs that are already approved.Under the bill, an already-approved drug intended to terminate a pregnancy may be dispensed to a patient only with a prescription. Furthermore, the FDA may not approve any labeling change that would authorize (1) using the drug after 70 days of gestation, or (2) dispensing the drug by any means other than in-person administration by the prescribing health care practitioner.The FDA must also impose additional restrictions on such already-approved drugs, including by (1) requiring the prescribing health care practitioner to receive a special certification, (2) prohibiting the practitioner from also acting as the dispensing pharmacist, and (3) requiring the practitioner to have the ability to provide surgical intervention to the patient.The bill also rescinds any investigational use exemption already granted to such a drug if the bill would have prohibited the FDA from granting the exemption. (Currently, the FDA may grant an exemption to certain market approval requirements if a drug is intended solely for use in safety and effectiveness investigations.)
US

Us Congress 2025-2026 Regular Session

Us Congress House Bill HB7

Introduced
1/22/25  
No Taxpayer Funding for Abortion and Abortion Insurance Full Disclosure Act of 2025
US

Us Congress 2025-2026 Regular Session

Us Congress House Bill HB703

Introduced
1/23/25  
Main Street Tax Certainty Act
US

Us Congress 2025-2026 Regular Session

Us Congress House Bill HB740

Introduced
1/28/25  
Refer
1/28/25  
Veterans’ ACCESS Act of 2025 Veterans’ Assuring Critical Care Expansions to Support Servicemembers Act of 2025
US

Us Congress 2025-2026 Regular Session

Us Congress House Bill HB747

Introduced
1/28/25  
Refer
1/28/25  
Report Pass
3/5/25  
Stop Chinese Fentanyl Act of 2025
US

Us Congress 2025-2026 Regular Session

Us Congress House Bill HB760

Introduced
1/28/25  
Refer
1/28/25  
Restoring Access to Mountain Homes Act
US

Us Congress 2025-2026 Regular Session

Us Congress House Bill HB833

Introduced
1/31/25  
Educational Choice for Children Act of 2025
US

Us Congress 2025-2026 Regular Session

Us Congress House Bill HB842

Introduced
1/31/25  
Nancy Gardner Sewell Medicare Multi-Cancer Early Detection Screening Coverage Act
US

Us Congress 2025-2026 Regular Session

Us Congress House Bill HB879

Introduced
1/31/25  
Medicare Patient Access and Practice Stabilization Act of 2025
US

Us Congress 2025-2026 Regular Session

Us Congress House Bill HB909

Introduced
2/4/25  
Crime Victims Fund Stabilization Act of 2025
US

Us Congress 2025-2026 Regular Session

Us Congress House Bill HB925

Introduced
2/4/25  
Dismantle DEI Act of 2025
US

Us Congress 2025-2026 Regular Session

Us Congress House Bill HB940

Introduced
2/4/25  
Refer
2/4/25  
FAIR Exams Act Fair Audits and Inspections for Regulators’ Exams Act
US

Us Congress 2025-2026 Regular Session

Us Congress House Bill HB941

Introduced
2/4/25  
Small LENDER Act Small Lenders Exempt from New Data and Excessive Reporting Act